A. Rubio

发表

Evolution of Genotypic Resistance to Nucleoside Analogues in Patients Receiving Protease Inhibitor-Containing Regimens

B. Clotet, L. Ruiz, M. Leal, 1998, Antiviral therapy.

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

B. Clotet, L. Ruiz, L. Stuyver, 2000, AIDS.

Low levels of HIV-1 plasma viral load in patients infected with HIV-1 subtype b and advanced immunosuppression.

M. Leal, J. Macías, J. Pineda, 2001, The Journal of infection.

Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood.

M. Leal, J. Macías, J. Pineda, 2001, Liver.

HIV-1 Plasma Viremia not Increased in Patients Receiving Highly Active Antiretroviral Therapy After Influenza Vaccination

M. Leal, J. Macías, J. Pineda, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Reduction of Immune System Activation in HIV-1-Infected Patients Undergoing Highly Active Antiretroviral Therapy

M. Leal, J. Macías, J. Pineda, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Fluorescence resonance energy transfer analysis of the RANTES polymorphisms -403G --> A and -28G --> C: evaluation of both variants as susceptibility factors to HIV type 1 infection in the Spanish population.

S. Borrego, G. Antiñolo, R. Fernández, 2003, AIDS research and human retroviruses.

Primary HIV‐1 drug resistance in Spain before and after the introduction of protease inhibitors

B. Clotet, L. Ruiz, V. Soriano, 2001, Journal of medical virology.

Presence of Genotypic Resistance in Nucleoside Analogue-Treated HIV-1-Infected Patients with Undetectable Viral Load

B. Clotet, L. Ruiz, L. Zamora, 1999, Antiviral therapy.

Efficiency of Drug Resistance Genotypic Tests in Specimens with Low HIV Viral Load

Soriano, B. Clotet, L. Ruiz, 1998, Antiviral therapy.

Genotypic resistance profile in treatment-experienced HIV-infected individuals after abacavir and efavirenz salvage regimen.

M. Leal, E. Lissen, A. Vallejo, 2004, Antiviral research.

Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy

E. Ruiz-Mateos, M. Leal, E. Lissen, 2003, AIDS.

T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy.

M. Leal, E. Lissen, A. Sánchez-Quijano, 2002, Blood.

Baseline Thymic Volume is a Predictor for CD4 T Cell Repopulation in Adult HIV-Infected Patients under Highly Active Antiretroviral Therapy

E. Ruiz-Mateos, M. Leal, E. Lissen, 2001, Antiviral therapy.

Thymic volume is associated independently with the magnitude of short‐ and long‐term repopulation of CD4+ T cells in HIV‐infected adults after highly active antiretroviral therapy (HAART) 1

E. Ruiz-Mateos, M. Leal, E. Lissen, 2004, Clinical and experimental immunology.

Changes in thymus volume in adult HIV‐infected patients under HAART: correlation with the T‐cell repopulation

E. Ruiz-Mateos, M. Leal, E. Lissen, 2002, Clinical and experimental immunology.

Evidence of thymic function in heavily antiretroviral-treated human immunodeficiency virus type 1-infected adults with long-term virologic treatment failure.

E. Ruiz-Mateos, M. Leal, E. Lissen, 2002, The Journal of infectious diseases.

Is hepatitis G virus transmitted sexually?

M. Leal, J. Pineda, E. Lissen, 1997, JAMA.

CD4+ and CD8+ T lymphocyte regeneration after anti‐retroviral therapy in HIV‐1‐infected children and adult patients

M. Leal, J. Macías, J. Pineda, 2000, Clinical and experimental immunology.

Spectrofluorimetric analysis of CCR5-delta 32 allele using real-time polymerase chain reaction: prevalence in southern Spanish HIV(+) patients and noninfected population.

S. Borrego, G. Antiñolo, M. Leal, 2001, AIDS research and human retroviruses.

Fluorescence resonance energy transfer analysis of CCR-V64I and SDF1-3'a polymorphisms: prevalence in southern Spain hiv type 1+ cohort and noninfected population.

S. Borrego, G. Antiñolo, J. Royo, 2001, AIDS research and human retroviruses.

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

V. Soriano, M. Leal, J. Arribas, 2001, AIDS.

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.

B Clotet, B. Clotet, L. Ruiz, 2001, AIDS.

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral‐naive and antiretroviral‐experienced HIV‐infected patients in Spain

B. Clotet, L. Ruiz, V. Soriano, 1998, AIDS.

Long‐term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug‐resistant genotypes

E. Domingo, J. Benito, M. Leal, 2004, Journal of medical virology.

Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996.

M. Leal, J. Pineda, E. Lissen, 1997, AIDS.

Short‐term evolution of HIV‐1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine

J. Pineda, E. Lissen, C. Rey, 1998, AIDS.

Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy.

V. Soriano, M. Leal, J. Macías, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Three episodes of tuberculosis–to multidrug resistance and back to susceptibility

V. Soriano, J. Pineda, A. Sánchez-Quijano, 2019 .

Usefulness of Route of Transmission, Absolute CD8+ T-Cell Counts, and Levels of Serum Tumor Necrosis Factor Alpha as Predictors of Survival of HIV-1-Infected Patients with Very Low CD4+ T-Cell Counts

M. Leal, J. Macías, J. Pineda, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Comparison of Thymic Function-Related Markers to Predict Early Cd4 T-Cell Repopulation in Adult HIV-Infected Patients on Haart

E. Ruiz-Mateos, M. Leal, E. Lissen, 2002, Antiviral therapy.

Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.

E. Ruiz-Mateos, M. Leal, M. Genebat, 2003, The Journal of antimicrobial chemotherapy.